Sharing Is Caring
US drug maker, Moderna announced that

the early-stage human trials for a coronavirus vaccine have shown encouraging signs, with the experimental injection inducing immune responses in healthy volunteers.
The company also noted that the vaccine was “generally safe and well tolerated” with the only adverse effect coming with one volunteer, who noted redness around the skin where the vaccine was injected.
The US Food and Drug Administration already gave the company approval to begin the phase two clinical trials, which it plans to launch in July.

Leave a Reply

%d bloggers like this: